Search form

Menu

Dan Markingson

The University of Minnesota is replacing the chairman of its psychiatry department following two scathing reviews of its safety protocols in research involving human subjects and its recruitment of a troubled man who later died by suicide in a schizophrenia drug trial.
Dan Markingson suffered from schizophrenia and killed himself in May 2004 while taking part in a clinical trial for an antipsychotic drug made by AstraZeneca. The evolving case continues to highlight problems of research oversight at the university and state levels.

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

A candid email from a university publicist sheds some, but not enough, light on why the university won't provide documents from a controversial Seroquel clinical study.

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

One of the biggest oversights a health writer can make is to cover a scientific study and not talk about its funders. William Heisel examines what can happen when a study's funding is overlooked.

Bioethicist and writer Carl Elliott used many documents to piece together the story of how a research team desperate for patients helped create a pipeline for clinical trial participants by setting up a psychiatric ward. Here's how he did it.

Documents behind a controversial Seroquel drug trial raise serious questions about how patients with mental disorders are judged competent to participate in clinical trials all over the world.

A war of words has erupted at the University of Minnesota campus over bioethics writer and UM professor Carl Elliott’s reporting into the suicide of a schizophrenic patient enrolled in a clinical trial.

Dr. Carl Elliott, a University of Minnesota bioethicist, has spent much of the last two years doggedly pursuing the case of Dan Markingson, a 26-year-old who killed himself during a UM clinical trial meant to prove the superiority of AstraZeneca’s Seroquel over its competitors.

CONNECT WITH THE COMMUNITY

Member Activities

Allan Brettman joined the community

Connect with Allan Brettman

Lenzy Krehbiel-Burton has shared a essay

Read it.

Sean Connelley's profile has been updated

Connect with Sean Connelley

Anna Romano has shared a blog post

Read it.

zack kaldveer's profile has been updated

Connect with zack kaldveer
More Member Activities

Follow Us

Facebook

Twitter

ReportingHealth